Willoughby Scott B.
Sangamo Therapeutics, Inc. · SVP
Willoughby Scott B. is listed in filings as SVP at Sangamo Therapeutics, Inc.. This profile follows SEC Form 4 activity through May 27, 2026, including 21 public disclosures. Recent filings connect the profile to Sangamo Therapeutics, Inc. (SGMO). The current snapshot covers public activity from Aug 15, 2024 to May 27, 2026. Reported amounts are shown as $703 to $5.8K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Current Price |
|---|---|---|---|---|
| Historical insider buys and sells before the latest disclosure date will appear here after more snapshots are available. | ||||